Cargando…
Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer
Cancer cachexia is a common, debilitating condition with limited therapeutic options. Using an established mouse model of lung cancer, we find that cachexia is characterized by reduced food intake, spontaneous activity, and energy expenditure accompanied by muscle metabolic dysfunction and atrophy....
Autores principales: | Queiroz, Andre Lima, Dantas, Ezequiel, Ramsamooj, Shakti, Murthy, Anirudh, Ahmed, Mujmmail, Zunica, Elizabeth R. M., Liang, Roger J., Murphy, Jessica, Holman, Corey D., Bare, Curtis J., Ghahramani, Gregory, Wu, Zhidan, Cohen, David E., Kirwan, John P., Cantley, Lewis C., Axelrod, Christopher L., Goncalves, Marcus D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360437/ https://www.ncbi.nlm.nih.gov/pubmed/35941104 http://dx.doi.org/10.1038/s41467-022-32135-0 |
Ejemplares similares
-
Akt Deficiency Attenuates Muscle Size and Function but Not the Response to ActRIIB Inhibition
por: Goncalves, Marcus D., et al.
Publicado: (2010) -
Identification of ligand-selective peptidic ActRIIB-antagonists using phage display technology
por: Sakamoto, Kotaro, et al.
Publicado: (2017) -
Preliminary Investigation into a Potential Role for Myostatin and Its Receptor (ActRIIB) in Lean and Obese Horses and Ponies
por: Morrison, Philippa K., et al.
Publicado: (2014) -
Adult-Specific Systemic Over-Expression Reveals Novel In Vivo Effects of the Soluble Forms of ActRIIA, ActRIIB and BMPRII
por: Yamawaki, Kengo, et al.
Publicado: (2013) -
Electrical impedance myography as a biomarker of myostatin inhibition with ActRIIB-mFc: a study in wild-type mice
por: Nagy, Janice A, et al.
Publicado: (2018)